Get started
Author

Honey Pavithran

ORCID: 0000-0001-8145-5581
Observed ORCID: 0000-0001-8145-5581
OpenAlex ID: A5091531678
Emergence of Cardiac Glycosides as Potential Drugs: Current and Future Scope for Cancer Therapeutics
2021 · Ranjith Kumavath, Sayan Paul, et al. · Biomolecules · 76
PDF
Effects of gut microbiome and obesity on the development, progression and prevention of cancer (Review)
2023 · Ranjith Kumavath, Honey Pavithran, et al. · International Journal of Oncology · 16
PDF
Transcriptome Profiling of Cardiac Glycoside Treatment Reveals EGR1 and Downstream Proteins of MAPK/ERK Signaling Pathway in Human Breast Cancer Cells
2023 · Honey Pavithran, Ranjith Kumavath, et al. · International Journal of Molecular Sciences · 14
PDF
In silico analysis of nsSNPs in CYP19A1 gene affecting breast cancer associated aromatase enzyme
2021 · Honey Pavithran, Ranjith Kumavath · Journal of Genetics · 13
Emerging role of pioneer transcription factors in targeted ERα positive breast cancer
2021 · Honey Pavithran, Ranjith Kumavath · Exploration of Targeted Anti-tumor Therapy · 6
PDF
Network and modeling analysis of MAPK signaling cascade uncovers EGR1 regulation through ERK2 protein in breast cancer
2025 · Honey Pavithran, Preetam Ghosh, et al. · Computers in Biology and Medicine · 1
Potential Therapeutic Effects of Flavonoids Against the COVID-19 Infection
2023 · R.B. Aswani, Honey Pavithran, et al. · CRC Press eBooks
Repurposing cardiac glycosides as the hallmark of immunogenic modulators in cancer therapy
2023 · Honey Pavithran, Angelina Job Kolady, et al. · Elsevier eBooks
Contributors
2023 · Shloka Adluru, Sarfraz Ahmad, et al. · Elsevier eBooks
Targeted inhibition of CD47 expression in Human cancer cell lines on treatment with Cardiac Glycosides
2022 · Ranjith Kumavath, Honey Pavithran · Research Square
PDF
Works count: 10
Citation count: 126
H-index: 5
I10-index: 4
Year
Topic
Type